|
DUSP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.265380E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.804500E-03 |
| Normal-vs-Stage2 |
8.532200E-01 |
| Normal-vs-Stage3 |
4.563800E-01 |
| Normal-vs-Stage4 |
9.246200E-01 |
| Stage1-vs-Stage2 |
4.133500E-02 |
| Stage1-vs-Stage3 |
8.863400E-03 |
| Stage1-vs-Stage4 |
8.015100E-04 |
| Stage2-vs-Stage3 |
6.454000E-01 |
| Stage2-vs-Stage4 |
7.674000E-01 |
| Stage3-vs-Stage4 |
3.436600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.511250E-01 |
| Normal-vs-AfricanAmerican |
1.691200E-01 |
| Normal-vs-Asian |
1.511160E-01 |
| Caucasian-vs-AfricanAmerican |
6.051200E-01 |
| Caucasian-vs-Asian |
6.239000E-01 |
| AfricanAmerican-vs-Asian |
8.158600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.160230E-01 |
| Normal-vs-Female |
1.904770E-01 |
| Male-vs-Female |
7.045800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.115000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.546440E-01 |
| Normal-vs-Age(61-80Yrs) |
1.135820E-01 |
| Normal-vs-Age(81-100Yrs) |
1.808230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.706800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.115800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.893400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.412000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.792200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.011800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.107400E-01 |
| Normal-vs-Grade 2 |
1.508200E-02 |
| Normal-vs-Grade 3 |
2.574200E-01 |
| Normal-vs-Grade 4 |
4.731400E-01 |
| Grade 1-vs-Grade 2 |
8.196400E-01 |
| Grade 1-vs-Grade 3 |
3.531200E-01 |
| Grade 1-vs-Grade 4 |
7.333700E-02 |
| Grade 2-vs-Grade 3 |
1.691950E-02 |
| Grade 2-vs-Grade 4 |
2.832600E-04 |
| Grade 3-vs-Grade 4 |
3.052000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.822300E-02 |
| Normal-vs-ccB subtype |
2.694800E-01 |
| ccA subtype-vs-ccB subtype |
1.565210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.104800E-01 |
| Normal-vs-N1 |
7.939200E-01 |
| N0-vs-N1 |
4.040800E-01 |
|
|
